CCO Interactive Case Challenges
CCO Interactive Case Challenges: Treatment of Advanced Renal Cell Carcinoma
Evolving Concepts in the Treatment of Advanced Renal Cell Carcinoma
|
Module 1 of 1
|
- Robert A. Figlin, MD, FACP
|
|
|
 Topics Covered Include:
-
Standard Immunotherapy for Advanced RCC
-
New Pathways for Therapeutic Modulation in RCC
-
Sorafenib and Sunitinib in RCC
-
New Directions with IL-2 and Interferon
-
Predictors of Response to IL-2: Clinical Factors, Tumor Subtype, and Molecular Markers
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review the evolving standard of care for first-line treatment of renal cell carcinoma
- Discuss how patient selection, based on clinical characteristics, tumor pathology, or molecular markers, may enhance outcomes in patients undergoing treatment for renal cell carcinoma
- Describe emerging research focused on identifying those patients most likely to benefit from therapy with interleukin-2
|
Interactive Case Challenges
Diagnosis and Treatment of Metastatic Renal Cell Carcinoma in a 58-Year-Old Male Smoker
- Robert A. Figlin, MD, FACP
- Hyung Kim, MD
|
|
|
 Test your ability to diagnose and treat a patient who presents to his primary physician with vague abdominal pain and has no history of kidney disease. Learning Objectives
Upon completion of this activity, participants should be able to:
- List the tests and evaluations that are appropriate for initial workup of a patient with suspected metastatic renal cell carcinoma (RCC)
- Describe treatment options for patients with advanced or recurrent renal cell carcinoma
- Identify patients with advanced or recurrent renal cell carcinoma who might be considered good candidates for immunotherapy, based on diagnostic and other considerations
|
Management of Metastatic Clear-Cell Renal Carcinoma in a 55-Year-Old Male Patient
 
- David F. McDermott, MD
- Michael B. Atkins, MD
|
|
|
Test your ability to manage a relatively healthy 55-year-old male with metastatic clear-cell renal carcinoma. Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify patients with advanced or recurrent renal cell carcinoma who might be considered good candidates for immunotherapy, based on diagnostic and other considerations
- Describe treatment options for patients with advanced or recurrent renal cell carcinoma
- Review management of side effects and potential toxicity associated with treatment of advanced or recurrent renal cell cancer
|
Diagnosis and Treatment of Metastatic Renal Cell Carcinoma in a Mildly Symptomatic 67-Year-Old Male Patient
|
|
|
Test your ability to manage a 67-year-old male with mildly symptomatic metastatic renal cell carcinoma. Learning Objectives
Upon completion of this activity, participants should be able to:
- List the examinations and evaluations that are important in obtaining an accurate diagnosis in patients with suspected metastatic renal cell carcinoma
- Describe treatment options for patients with advanced renal cell carcinoma
- Identify patient-specific factors that may have prognostic or predictive significance in the treatment of metastatic renal cell carcinoma
|
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|